Articles from The Pershing Square Foundation

The Pershing Square Foundation today announced the 2026 Lotus Award (formerly the Ovarian Cancer Challenge Grant), a competitive funding program to accelerate breakthrough research in ovarian cancer. Each recipient will receive $250,000 per year for three years ($750,000 total) to pursue high-risk, high-reward science with potential for transformative impact. Applications for the 2026 Lotus Award are currently being accepted until Monday, February 2nd at 5:00pm ET.

The Pershing Square Sohn Cancer Research Alliance (PSSCRA) today announced the opening of applications for the 2026 Pershing Square Sohn Cancer Prize. The award of $250,000 per year for three years is granted annually to a minimum of six scientists, depending on the quality of the proposals. The Prize empowers researchers to pursue novel, high-risk/high-reward cancer research at a stage when traditional funding is lacking. While the Prize originally started as an effort to support cancer research in the greater New York City area, this year, the Prize eligibility has expanded to include scientists across the United States.

The Pershing Square Foundation today announced the opening of applications for the 2026 MIND (Maximizing Innovation in Neuroscience Discovery) Prize. Since the Prize launched in 2023, it has been awarded to 20 multidisciplinary investigators from institutions across the country. The annual prize awards $250,000 per year for three years ($750,000 total) to at least six scientists looking to uncover a deeper understanding of the brain and cognition, with a lens on Alzheimer’s Disease and Dementias. The Prize is meant to enable the most talented early-to-mid-career investigators to pursue bold, creative projects that could have transformative impacts on the field of brain research.

The Pershing Square Foundation (the “Foundation”) today announced that it has awarded $5.25M to seven groundbreaking scientists at five premier institutions. For over a decade, the Foundation has advanced health initiatives in New York City by funding pioneering cancer researchers through the Pershing Square Sohn Cancer Research Alliance (“PSSCRA”). Expanding on its enduring commitment to cancer research and its broader investments in women’s health over the years, the Foundation has launched a new initiative focused on raising awareness to spotlight ovarian cancer. This bold initiative tackles one of the most lethal and underfunded cancers impacting women today, bringing together some of the world’s most brilliant minds to address this critical public health crisis.

The Pershing Square Sohn Cancer Research Alliance today announced the six winners of the 2025 Pershing Square Sohn Cancer Prize, awarded annually to cancer research scientists and physician-scientists based in the greater New York City area. The Prize, totaling $4.5 million distributed in $750,000 grants to each winner, empowers investigators early in their independent careers to pursue their most exciting research projects at a critical stage when traditional funding is lacking.

The Pershing Square Foundation today announced the six winners of the “MIND” Prize (Maximizing Innovation in Neuroscience Discovery). Through the Prize, the Foundation strives to change the paradigm of neuroscience research by creating a community of next-frontier thinkers who can uncover a deeper understanding of the brain and cognition. Breakthroughs in basic scientific and translational research will yield critical tools for and knowledge of neurodegenerative diseases, including Alzheimer’s Disease and Dementia, which affect millions of people worldwide.

The Pershing Square Foundation has announced the opening of applications for the 2025 MIND (Maximizing Innovation in Neuroscience Discovery) Prize. Since the Prize launched in 2023, it has been awarded to 14 multidisciplinary investigators from institutions across the country. The annual prize awards $250,000 per year for three years ($750,000 total) to six scientists looking to uncover a deeper understanding of the brain and cognition. The Prize is meant to enable the most talented early-to-mid-career investigators to pursue bold, creative projects that could have transformative impacts on the field of brain research.

The Pershing Square Sohn Cancer Research Alliance (PSSCRA) today announced the opening of applications for the 2025 Pershing Square Sohn Cancer Prize (formerly known as the Pershing Square Sohn Prize for Young Investigators in Cancer Research). The prize of $250,000 per year for three years is awarded annually to six scientists who are based in the greater New York City area. The Prize empowers researchers to pursue novel, high-risk/high-reward cancer research at a stage when traditional funding is lacking.

The Pershing Square Sohn Cancer Research Alliance today announced the five winners of the 2024 Pershing Square Sohn Prize for Young Investigators in Cancer Research, awarded annually to cancer research scientists and physician-scientists based in the greater New York City area. The Prize, totaling $3.75 million, empowers investigators early in their independent careers to pursue their most exciting research projects at a critical stage when traditional funding is lacking. Recipients receive $250,000 per year for three years.

The Pershing Square Foundation today announced $2M in grants to a group of twelve Newark organizations. The Pershing Square Foundation selected organizations that provide critical services to the community.

The Pershing Square Foundation today announced the seven winners of the “MIND” Prize (Maximizing Innovation in Neuroscience Discovery). Through the Prize, the Foundation strives to change the paradigm of neuroscience research by creating a community of next-frontier thinkers who can uncover a deeper understanding of the brain and cognition. Breakthroughs in basic scientific and translational research will yield critical tools for and knowledge of neurodegenerative diseases, including Alzheimer’s Disease and Dementia, which affect millions of people worldwide.

The Pershing Square Foundation has announced the opening of applications for the 2024 MIND (Maximizing Innovation in Neuroscience Discovery) Prize. Since the Prize launched in 2023, it has been awarded to seven multidisciplinary investigators from institutions across the country. The annual prize awards $250,000 per year for three years ($750,000 total) to at least six scientists looking to uncover a deeper understanding of the brain and cognition. The Prize is meant to enable the most talented early-to-mid-career investigators to pursue bold, creative projects that could have transformative impacts on the field of brain research.

The Pershing Square Sohn Cancer Research Alliance (PSSCRA) today announced the opening of applications for the 2024 Pershing Square Sohn Prize for Young Investigators in Cancer Research. The prize of $250,000 per year for three years is awarded annually to at least six New York City area-based scientists. The Prize empowers researchers to pursue novel, high-risk/high-reward cancer research at a stage when traditional funding is lacking.

The Pershing Square Sohn Cancer Research Alliance today announced the seven winners of the 2023 Pershing Square Sohn Prize for Young Investigators in Cancer Research, awarded annually to cancer research scientists and physician-scientists based in the greater New York City area. The Prize empowers investigators early in their independent careers to pursue their most exciting research projects at a critical stage when traditional funding is lacking. Recipients receive $250,000 per year for three years, totaling $750,000 per awardee.

The Pershing Square Foundation today announced the seven winners of the inaugural “MIND” Prize (Maximizing Innovation in Neuroscience Discovery). Through the Prize, the Foundation strives to change the paradigm of neuroscience research by creating a community of next-frontier thinkers who can uncover a deeper understanding of the brain and cognition. Breakthroughs in basic scientific and translational research will yield critical tools for and knowledge of neurodegenerative diseases, including Alzheimer’s Disease and Dementia, which affect millions of people worldwide.

The Pershing Square Foundation today announced the launch of the MIND (“Maximizing Innovation in Neuroscience Discovery”) Prize. With the launch of the Prize, The Foundation strives to change the paradigm of neuroscience research by creating a community of next-frontier thinkers who can uncover a deeper understanding of the brain and cognition. Breakthroughs in basic scientific and translational research will yield critical tools for and knowledge of neurodegenerative diseases, including Alzheimer’s Disease and Dementia, which affect millions of people worldwide. The Prize will bring together the most talented early-to-mid-career investigators across scientific fields with creative and experimental ideas to solve problems that will transform the current understanding of the brain and its impact on human health.

The Pershing Square Sohn Cancer Research Alliance (PSSCRA) today announced the opening of applications for the 2023 Pershing Square Sohn Prize for Young Investigators in Cancer Research. The prize of $200,000 per year for three years is awarded annually to at least six New York City area-based scientists. The Prize empowers researchers to pursue novel, high-risk/high-reward cancer research at a stage when traditional funding is lacking.

The Pershing Square Sohn Cancer Research Alliance today announced the seven winners of the 2022 Pershing Square Sohn Prize for Young Investigators in Cancer Research, awarded annually to cancer research scientists and physician-scientists based in the greater New York City area. The Prize, totaling $4.2 million, empowers investigators early in their independent careers to pursue their most exciting research projects at a critical stage when traditional funding is lacking. Recipients receive $200,000 per year for three years.

The Pershing Square Sohn Cancer Research Alliance (PSSCRA) today announced the opening of applications for the 2022 Pershing Square Sohn Prize for Young Investigators in Cancer Research. The prize of $200,000 per year for three years is awarded annually to at least six New York City area-based scientists. The prize empowers researchers to pursue novel, high-risk/high-reward cancer research at a stage when traditional funding is lacking.

The Pershing Square Sohn Cancer Research Alliance today announced the six winners of the 2021 Pershing Square Sohn Prize for Young Investigators in Cancer Research, awarded annually to cancer research scientists and physician-scientists based in the greater New York City area. The Prize, totaling $3.6 million, empowers investigators early in their independent careers to pursue research projects at a critical stage when traditional funding is lacking. Recipients receive $200,000 per year for three years.